Search

Your search keyword '"Hirschberg Y"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Hirschberg Y" Remove constraint Author: "Hirschberg Y"
36 results on '"Hirschberg Y"'

Search Results

2. 718P A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment

3. Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma

4. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

8. Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)

14. 35th Annual Meeting of the European Association for the Study of Diabetes

15. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

19. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview.

20. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia.

21. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview.

22. Characterising extracellular vesicles from individual low volume cerebrospinal fluid samples, isolated by SmartSEC.

23. Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results.

24. Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective.

25. Altered age-linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT-preAD study) with high brain amyloid load.

26. Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma.

27. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).

28. Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.

29. In vitro and in situ permeability of a 'second generation' hydroxypyridinone oral iron chelator: correlation with physico-chemical properties and oral activity.

30. Oral absorption of CGS-20625, an insoluble drug, in dogs and man.

31. The response to endotoxin in guinea pigs after intravenous black currant seed oil.

32. The effects of chronic fish oil feeding in rats on protein catabolism induced by recombinant mediators.

33. Decreased loss of liver nucleotides and energy charge during hypothermic preservation by donor pretreatment with glucose--a preliminary report.

34. Glycolytic support of adenine nucleotides in rat liver flush-preserved with UW or Collins' II. Importance of donor nutritional status.

35. Serum fatty acid profiles after intravenous medium chain triglyceride administration.

36. Decreased loss of liver adenosine triphosphate during hypothermic preservation in rats pretreated with glucose: implications for organ donor management.

Catalog

Books, media, physical & digital resources